BIONX IMPLANTS' SR-PGA RESORBABLE UROLOGY STENT MARKETING SUBMISSION EXPECTED LATER THIS YEAR; DEVICE IS FIRST RESORBABLE STENT FOR UROLOGIC USE
This article was originally published in The Gray Sheet
Executive Summary
Bionx Implants is planning to submit a marketing application for its SR-PGA resorbable urology stent to FDA later this year, the company says in a preliminary prospectus for an initial public offering filed with the Securities and Exchange Commission on March 13. Bionx has not yet determined whether FDA will require a premarket approval application or a 510(k) for the device.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.